Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Successful interim analysis of phase II alfimeprase study

Sep. 30, 2003

OBI-1 undergoes testing in hemophilia A patients

Sep. 30, 2003

Novel TF/factor VIIa inhibitors under study at Roche

Sep. 26, 2003

3DP presents new orally active thrombin inhibitors at ACS meeting

Sep. 25, 2003

Phase IIIa study of Neutralase halted

Sep. 25, 2003

Dual thrombin/factor Xa inhibitors evaluated as anticoagulants

Sep. 23, 2003

Novel benzamidine-based factor Xa inhibitors in Morphochem pipeline

Sep. 22, 2003

BMS-561389/DPC-906 as a phase II candidate for oral anticoagulant therapy

Sep. 18, 2003

Ximelagatran prevents recurrence of cardiovascular events after myocardial infarction

Sep. 18, 2003

New antithrombotic serine protease inhibitor patented by former Pharmacia

Sep. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...